Advertisement
Advertisement

NVAX

NVAX logo

Novavax Inc

10.22
USD
Sponsored
-0.12
-1.16%
Sep 04, 15:59 UTC -4
Closed
exchange

After-Market

10.20

-0.02
-0.20%

NVAX Earnings Reports

Positive Surprise Ratio

NVAX beat 20 of 43 last estimates.

47%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$74.11M
/
-$0.23
Implied change from Q2 26 (Revenue/ EPS)
+30.71%
/
-28.13%
Implied change from Q3 25 (Revenue/ EPS)
+5.20%
/
-81.60%

Novavax Inc earnings per share and revenue

On Aug 06, 2026, NVAX reported earnings of -0.32 USD per share (EPS) for Q2 26, beating the estimate of -0.39 USD, resulting in a 18.64% surprise. Revenue reached 56.70 million, compared to an expected 53.56 million, with a 5.85% difference. The market reacted with a +0.52% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 7 analysts forecast an EPS of -0.23 USD, with revenue projected to reach 74.11 million USD, implying an decrease of -28.13% EPS, and increase of 30.71% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Clinuvel Pharmaceuticals Limited - ADR
Report Date
Aug 27, 2026 For Q4 26
Estimate
$0.50
Actual
-
Surprise
-
logo
Anavex Life Sciences
Report Date
Aug 25, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+1.96%
logo
Molecular Partners AG - ADR
Report Date
Aug 25, 2026 For Q2 26
Estimate
-
Actual
-$0.35
Surprise
-
FAQ
For Q2 2026, Novavax Inc reported EPS of -$0.32, beating estimates by 18.64%, and revenue of $56.70M, 5.85% above expectations.
The stock price moved up 0.52%, changed from $7.70 before the earnings release to $7.74 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on 7 analysts, Novavax Inc is expected to report EPS of -$0.23 and revenue of $74.11M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement